AEMD Stock Analysis: Buy, Sell, or Hold?
AEMD - AETHLON MEDICAL INC
$2.10
-0.11 (-4.98%)
βΌ
5d:
-31.6%
30d:
-12.5%
90d:
+14.75%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jun 25, 2026
21d
Get Alerted When AEMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called AEMD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: AEMD is down 31.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: AEMD is down 31.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AEMD is currently trading at $2.10, which is considered fair relative to its 30-day fair value range of $2.05 to $2.50.
Technical Outlook: Technically, AEMD is in a uptrend. Immediate support is located at $1.98, while resistance sits at $3.18. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.75 (+126.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEMD is in a uptrend. Immediate support is located at $1.98, while resistance sits at $3.18. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.75 (+126.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.05 -
$2.50
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 126.2% below Wall St target ($4.75)
- WARNING: Recommendation downgraded due to -31.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.05 -
$2.50
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.98
Resistance Level
$3.18
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.14
Wall Street Target
$4.75
(+126.2%)
Revenue Growth (YoY)
4278.2%
Share & Embed Analysis
Last updated: June 03, 2026 5:23 PM ET
Data refreshes hourly during market hours. Next update: 6:23 PM
Data refreshes hourly during market hours. Next update: 6:23 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 54 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$247 | 62 BUY |